Tema Cardiovascular and Metabolics ETF (HRTS) Holdings → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free HRTS Stock Alerts $32.67 -0.23 (-0.70%) (As of 05/17/2024 ET) Add Compare Share Share HoldingsStock AnalysisChartHeadlinesHoldingsRatingsSocial MediaStock AnalysisChartHeadlinesHoldingsRatingsSocial Media Top 45 HRTS HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$445.21+1.0%5.39%8,0542AMGNAmgen$312.47-0.7%5.34%10,9043LLYEli Lilly and Company$770.00-0.1%4.96%3,9114Novo Nordisk A/S Class BN/A4.70%22,6335DXCMDexCom$131.36-0.4%4.25%20,0196PODDInsulet$187.27+1.0%3.07%10,210 Get the Latest News and Ratings for HRTS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Cardiovascular and Metabolics ETF and its competitors with MarketBeat's FREE daily newsletter. 7CRNXCrinetics Pharmaceuticals$51.40-1.0%2.96%38,1448CYTKCytokinetics$59.53-0.7%2.86%26,8689MDTMedtronic$85.92+0.3%2.83%21,16810EWEdwards Lifesciences$89.14-1.1%2.80%20,03411ALNYAlnylam Pharmaceuticals$149.40-1.2%2.79%11,08312BBIOBridgeBio Pharma$30.09-3.1%2.68%59,22713Novartis AG Registered SharesN/A2.66%16,49914BSXBoston Scientific$74.65+0.1%2.62%21,92415NARIInari Medical$45.75-1.2%2.62%37,48116ASNDAscendis Pharma A/S$121.12-1.4%2.60%11,71817Chugai Pharmaceutical Co LtdN/A2.59%49,32918RCKTRocket Pharmaceuticals$22.62-3.3%2.52%66,18119MREOMereo BioPharma Group$3.20-2.1%2.43%494,42420NTLAIntellia Therapeutics$26.22+0.2%2.33%59,72221VKTXViking Therapeutics$67.00-3.0%2.30%17,69222RAREUltragenyx Pharmaceutical$41.87-1.7%2.29%33,45323WSTWest Pharmaceutical Services$355.64+0.4%2.25%3,74924BMYBristol-Myers Squibb$44.03-0.2%2.11%29,37825IONSIonis Pharmaceuticals$37.31-0.8%2.08%31,22026MASIMasimo$124.10+2.9%2.05%9,26127Zealand Pharma A/SN/A1.95%12,54028First American Treasury Obligs XN/A1.76%1,078,15729KROSKeros Therapeutics$52.28-3.2%1.75%18,25630MLYSMineralys Therapeutics$13.00-1.1%1.72%74,27731OMCLOmnicell$30.44-3.9%1.60%32,43532ARWRArrowhead Pharmaceuticals$24.77-0.9%1.48%36,28833MIRMMirum Pharmaceuticals$24.07-2.7%1.45%34,36634MDGLMadrigal Pharmaceuticals$220.06+1.3%1.36%3,83835OSCROscar Health$22.52+1.7%1.36%42,19336SWAVShockwave Medical$330.13-0.2%1.25%2,32037AKROAkero Therapeutics$19.92-3.9%1.19%33,10438ARCTArcturus Therapeutics$29.78-2.4%1.08%24,08939TNYATenaya Therapeutics$4.66+9.6%0.98%129,96840SLNOSoleno Therapeutics$46.16+1.1%0.82%10,784Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover41SLNSilence Therapeutics$23.00+0.3%0.71%19,59342GPCRStructure Therapeutics$36.15+0.8%0.67%10,44443VERVVerve Therapeutics$5.98-6.3%0.43%42,71544SKYESkye Bioscience$12.05-1.6%0.31%14,70745DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A0.07%268,299,793 Geographic ExposureUnited States85.4%Denmark6.1%Switzerland2.7%Japan2.5%Currency ExposureUSD88.6%DKK6.1%CHF2.7%JPY2.5%Sector ExposureHealth Care67.5%Technology1.7%Industrials1.2%Industry ExposureBiotechnology47.9%Health Care Equipment & Supplies16.8%Pharmaceuticals2.7%Software1.7%Commercial Services & Supplies1.2%SubIndustry ExposureBiotechnology45.3%Health Care Equipment15.9%Pharmaceuticals2.7%Health Care Supplies2.1%Application Software1.7%Coupon Exposure4-61.8%Maturity Exposure15-201.8% Related Companies and Tools Related Companies: Global X Data Center & Digital Infrastructure ETF Portfolio Companies Global X Aging Population ETF Portfolio Companies Global X Data Center & Digital Infrastructure ETF Portfolio Companies AXS 2X Innovation ETF Portfolio Companies iShares Paris-Aligned Climate MSCI World ex USA ETF Portfolio Companies CrossingBridge Pre-Merger SPAC ETF Portfolio Companies Siren Nasdaq NexGen Economy ETF Portfolio Companies Spear Alpha ETF Portfolio Companies Global X Telemedicine & Digital Health ETF Portfolio Companies Global X Clean Tech ETF Portfolio Companies This page (NASDAQ:HRTS) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaA letter is coming from the "Bureau of the Fiscal Service".Stansberry ResearchCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceBill Clinton Backing Biden Replacement???The Freeport SocietyUrgent Nvidia WarningAltimetryForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Cardiovascular and Metabolics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
